Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 3
2006 1
2007 5
2008 8
2009 3
2010 5
2011 2
2012 3
2013 2
2014 6
2015 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Development of a rational scale to assess the harm of drugs of potential misuse.
Nutt D, King LA, Saulsbury W, Blakemore C. Nutt D, et al. Lancet. 2007 Mar 24;369(9566):1047-53. doi: 10.1016/S0140-6736(07)60464-4. Lancet. 2007. PMID: 17382831 Review.
Opioids and anxiety.
Colasanti A, Rabiner EA, Lingford-Hughes A, Nutt DJ. Colasanti A, et al. J Psychopharmacol. 2011 Nov;25(11):1415-33. doi: 10.1177/0269881110367726. Epub 2010 Jun 8. J Psychopharmacol. 2011. PMID: 20530588 Review.
Neuropharmacology of addiction and how it informs treatment.
Lingford-Hughes A, Watson B, Kalk N, Reid A. Lingford-Hughes A, et al. Br Med Bull. 2010;96:93-110. doi: 10.1093/bmb/ldq032. Epub 2010 Nov 2. Br Med Bull. 2010. PMID: 21044987 Review.
Addiction: the clinical interface.
Nutt D, Lingford-Hughes A. Nutt D, et al. Br J Pharmacol. 2008 May;154(2):397-405. doi: 10.1038/bjp.2008.101. Epub 2008 Apr 14. Br J Pharmacol. 2008. PMID: 18414399 Free PMC article. Review.
GABAB receptors in addiction and its treatment.
Tyacke RJ, Lingford-Hughes A, Reed LJ, Nutt DJ. Tyacke RJ, et al. Adv Pharmacol. 2010;58:373-96. doi: 10.1016/S1054-3589(10)58014-1. Adv Pharmacol. 2010. PMID: 20655489 Review.
Effects of cannabis use on outcomes of psychotic disorders: systematic review.
Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Zammit S, et al. Br J Psychiatry. 2008 Nov;193(5):357-63. doi: 10.1192/bjp.bp.107.046375. Br J Psychiatry. 2008. PMID: 18978312 Review.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
Soyka M, Kranzler HR, Berglund M, Gorelick D, Hesselbrock V, Johnson BA, Möller HJ; WFSBP Task Force on Treatment Guidelines for Substance Use Disorders. Soyka M, et al. World J Biol Psychiatry. 2008;9(1):6-23. doi: 10.1080/15622970801896390. World J Biol Psychiatry. 2008. PMID: 18273737 Review.
Is socioeconomic status in early life associated with drug use? A systematic review of the evidence.
Daniel JZ, Hickman M, Macleod J, Wiles N, Lingford-Hughes A, Farrell M, Araya R, Skapinakis P, Haynes J, Lewis G. Daniel JZ, et al. Drug Alcohol Rev. 2009 Mar;28(2):142-53. doi: 10.1111/j.1465-3362.2008.00042.x. Drug Alcohol Rev. 2009. PMID: 19320699 Review.
Measurement of GABA using J-difference edited 1H-MRS following modulation of synaptic GABA concentration with tiagabine.
Myers JF, Evans CJ, Kalk NJ, Edden RA, Lingford-Hughes AR. Myers JF, et al. Synapse. 2014 Aug;68(8):355-62. doi: 10.1002/syn.21747. Epub 2014 May 2. Synapse. 2014. PMID: 24756906
A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist.
Lingford-Hughes A, Wilson SJ, Feeney A, Grasby PG, Nutt DJ. Lingford-Hughes A, et al. Psychopharmacology (Berl). 2005 Aug;180(4):789-91. doi: 10.1007/s00213-005-0060-1. Epub 2005 Sep 14. Psychopharmacology (Berl). 2005. PMID: 15986186 Clinical Trial. No abstract available.
33 results
Jump to page
Feedback